Benzinga | Dec 14, 2021 06:06AM EST

SVB Leerink Downgrades Arena Pharmaceuticals to Market Perform, Lowers Price Target to $100

SVB Leerink analyst Joseph Schwartz downgrades Arena Pharmaceuticals (NASDAQ:ARNA) from Outperform to Market Perform and lowers the price target from $112 to $100.